BUSCADOR RECOLECTA

Dataset.

Dataset related to article: Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245485
Digital.CSIC. Repositorio Institucional del CSIC
  • Koller, Dora
  • Almenara, Susana
  • Mejía, Gina
  • Saiz-Rodríguez, Miriam
  • Zubiaur, Pablo
  • Román, Manuel
  • Ochoa, Dolores
  • Wojnicz, Aneta
  • Martín, Samuel
  • Romero-Palacián, Daniel
  • Navares-Gómez, Marcos
  • Abad-Santos, Francisco
[Adverse Drug Reactions and CT] The xls file shows relevant information about the treatment with aripiprazole and olanzapine, as well as about their possible adverse effects and the frequency with which they occur. [Genotypes] This is a doc files where It is showm the genotype and phenotype frequencies of the analysed polymorphisms, [Objective] To assess adverse events (AEs) and safety of aripiprazole (ARI) and olanzapine (OLA) treatment. [Conclusions] OLA induced more cardiovascular changes; however, more ADRs were registered to ARI. In addition, some polymorphisms may explain the difference in the incidence of these effects among subjects., European Comission ITN Treatment H2020-MSCA-ITN-721236, Peer reviewed
 
Proyecto: EC/H2020/721236

DOI: http://hdl.handle.net/10261/245485
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245485

HANDLE: http://hdl.handle.net/10261/245485
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245485
 
Ver en: http://hdl.handle.net/10261/245485
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245485
Go back
×

1 Versiones

Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245485
Dataset. 2021

DATASET RELATED TO ARTICLE: SAFETY AND CARDIOVASCULAR EFFECTS OF MULTIPLE-DOSE ADMINISTRATION OF ARIPIPRAZOLE AND OLANZAPINE IN A RANDOMISED CLINICAL TRIAL

Digital.CSIC. Repositorio Institucional del CSIC
  • Koller, Dora
  • Almenara, Susana
  • Mejía, Gina
  • Saiz-Rodríguez, Miriam
  • Zubiaur, Pablo
  • Román, Manuel
  • Ochoa, Dolores
  • Wojnicz, Aneta
  • Martín, Samuel
  • Romero-Palacián, Daniel
  • Navares-Gómez, Marcos
  • Abad-Santos, Francisco
[Adverse Drug Reactions and CT] The xls file shows relevant information about the treatment with aripiprazole and olanzapine, as well as about their possible adverse effects and the frequency with which they occur. [Genotypes] This is a doc files where It is showm the genotype and phenotype frequencies of the analysed polymorphisms, [Objective] To assess adverse events (AEs) and safety of aripiprazole (ARI) and olanzapine (OLA) treatment. [Conclusions] OLA induced more cardiovascular changes; however, more ADRs were registered to ARI. In addition, some polymorphisms may explain the difference in the incidence of these effects among subjects., European Comission ITN Treatment H2020-MSCA-ITN-721236, Peer reviewed

Proyecto: EC/H2020/721236
HANDLE: http://hdl.handle.net/10261/245485


Help guide

1106